ClinConnect ClinConnect Logo
Search / Trial NCT04028336

The Strategy of "Pulmonary Opening by Titration of Positive End-expiratory Pressure" Means of a Pulmonary Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome: for Which Patients?

Launched by CENTRE HOSPITALIER DE LENS · Jul 19, 2019

Trial Information

Current as of April 27, 2025

Terminated

Keywords

ClinConnect Summary

It will be a prospective interventional study in resuscitation patients with severe or moderate ARDS. This study will be multicentric between the University Hospital of Amiens and intensive care of Lens, intensive care of Bethune and intensive care of Arras. All patients in intensive care and severe, moderate ARDS will be included in this study. All patients will benefit from Lung ultrasound (LUS) with a mapping of each lung looking for normal or pathological lung profiles, as well as a measurement of esophageal pressure (Peso) at rest. A "PEP titration pulmonary opening" (PEP-OP) test usin...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Will be included in the study, patients:
  • Major patient (age ≥18 years)
  • Controlled assisted ventilation, sedation and curarization adapted to the respirator.
  • Within the first 72 hours of an ARDS (PaO2 / FiO2 ≤ 200 mmHg, FiO2 ≥ 60% and PEEP of ≥5 cmH20) (as recommended by the Berlin criteria)
  • Decision of intensivist in charge of the patient to put an oesophageal probe
  • After hemodynamic optimization (evaluation of the preload dependence and need for catecholamines)
  • Decision of the intensivist in charge of the patient to perform a pulmonary opening test by titration of PEEP by means of a pulmonary recruitment test.
  • Exclusion Criteria:
  • Patients under the age of 18
  • Pregnant women, women who are parturient or breastfeeding
  • Patients with pulmonary broncho-emphysematous pathology or at risk of presenting it.
  • Patients with a history of barotrauma or at risk of presenting it.
  • Patients with a history of intracranial hypertension
  • Patients with suspected or proven right ventricular dysfunction or uncontrolled hemodynamic instability after hemodynamic management.
  • Patients with a contraindication to the placement of an oesophageal tube (esophageal surgery, severe esophageal pathology)
  • Patients under guardianship or curatorship or deprived of liberty.
  • Patients who are legally protected
  • Patient not covered by French national health insurance

About Centre Hospitalier De Lens

Centre Hospitalier de Lens is a leading healthcare institution in France, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent sponsor, the hospital collaborates with multidisciplinary teams of healthcare professionals to conduct rigorous studies aimed at evaluating new treatments and therapeutic approaches. With a commitment to high ethical standards and patient safety, Centre Hospitalier de Lens fosters an environment that encourages scientific inquiry and the development of evidence-based practices, ultimately striving to enhance health outcomes for diverse populations.

Locations

Amiens, , France

Arras, , France

Béthune, , France

Lens, , France

Patients applied

0 patients applied

Trial Officials

Julien MARC, DR

Principal Investigator

Hospital of Lens

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials